CMS OKs new payment code for outpatient remdesivir administration

CMS approved a new payment code for the administration of remdesivir, an antiviral drug authorized to treat COVID-19, in an outpatient setting.

Advertisement

The approved Healthcare Common Procedure Coding System code is J0248 for administration of Veklury, the brand name of Gilead Sciences’ remdesivir.

The payment code could be used for dates of service on or after Dec. 23, 2021.

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.